| TRDA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the TRDA shares outstanding history going back to 10/31/2022:
Also see: TRDA Market Cap History TRDA YTD Return |
As of 7/31/2026 Entrada Therapeutics has 38.94 million TRDA shares outstanding. Investors often track the TRDA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TRDA share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 10/31/2022.

| TRDA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the TRDA shares outstanding history going back to 10/31/2022:
Also see: TRDA Market Cap History TRDA YTD Return |
| TRDA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
TRDA Historical Shares Outstanding: +5.90% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| TRDA Stock Price Chart |
| About Entrada Therapeutics Inc |
| Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a class of medicines, which engages intracellular targets that have long been considered inaccessible. Co.'s Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform (EEV Platform), the Co. is building a robust development portfolio of therapeutic candidates. Its first two drug candidates, ENTR-601-44 and VX-670, are in clinical trials. We show 16 historical shares outstanding datapoints in our coverage of TRDA's shares outstanding history. Understanding the changing numbers of TRDA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TRDA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TRDA by allowing them to research TRDA shares outstanding history as well as any other stock in our coverage universe. |
| TRDA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| TRDA Share Performance |
| Shares Outstanding Peers |
| Entrada Therapeutics (TRDA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TRLV Shares Outstanding History TRML Shares Outstanding History TROV Shares Outstanding History TRVI Shares Outstanding History TRVN Shares Outstanding History TSBX Shares Outstanding History TSHA Shares Outstanding History TSRO Shares Outstanding History TSVT Shares Outstanding History TTNP Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.